Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,070,012
-
Share change
-
-10,858,651
-
Total reported value
-
$3,062,000
-
Price per share
-
$0.22
-
Number of holders
-
36
-
Value change
-
-$2,439,500
-
Number of buys
-
16
-
Number of sells
-
11
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q4 2019
As of 31 Dec 2019,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,070,012 shares.
The largest 10 holders included
VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, BlackRock Inc., PNC Financial Services Group, Inc., RENAISSANCE TECHNOLOGIES LLC, Endurant Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.